Thermo Fisher Scientific Inc.
TMO
Market Cap$228.67B
Close$
Earnings Call Q2 2024
July 24, 2024 - AI Summary
Thermo Fisher Scientific reported strong financial results for the second quarter, exceeding expectations and leading to an increase in their 2024 guidance.
The company's revenue for Q2 was $10.54 billion, with adjusted operating income of $2.35 billion and adjusted EPS of $5.37 per share, representing a 4% increase year-over-year.
Thermo Fisher's growth strategy, focused on high impact innovation, trusted partnerships with customers, and a strong commercial engine, continues to drive success across its four end markets: pharma and biotech, academic and government, industrial and applied, and diagnostics and healthcare.
Exclusive for Stockcircle Pro members
Sign up
$988.31
65.1% upside
Current Fair Value
65.1% upsideUndervalued by 65.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $228.67 Billion |
|---|---|
| Enterprise Value | $257.00 Billion |
| Dividend Yield | $1.56 (0.253921585005262%) |
| Earnings per Share | $15.53 |
| Beta | 0.78 |
| Outstanding Shares | 382,000,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 36.76 |
|---|---|
| PEG | 252.66 |
| Price to Sales | 5.44 |
| Price to Book Ratio | 4.83 |
| Enterprise Value to Revenue | 6.07 |
| Enterprise Value to EBIT | 37.58 |
| Enterprise Value to Net Income | 41 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.75 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Thermo Fisher Scientific Inc.
75,000 employees
CEO: Marc Casper Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are acceleratin...